• Home
  • Sector News
    • Technology
    • Energy
    • Financial Services
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report

Subscribe to stay informed!

Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

What's Hot

When will the stock-market pain end? Here are 3 clues investors should watch for.

September 26, 2023

Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

September 26, 2023

What’s In Store For CarMax In Q2 – Analyst Sees Easing Growth Comparisons, Cost Controls & More – CarMax (NYSE:KMX)

September 26, 2023
Telegram RSS
  • Government
  • Press Releases
  • Stock Market
  • Top Stories
  • Trading Insights
  • Trending
  • About Us
Telegram RSS
Virtus Junxit EquitiesVirtus Junxit Equities
  • Home
  • Sector News
    1. Technology
    2. Energy
    3. Financial Services
    4. View All

    American Society for Clinical Pathology Awarded $631,983 Grant from the CDC to Strengthen the Laboratory Workforce

    September 26, 2023

    OpenAI Discusses Share Sale: Potential $90B Valuation Signals AI Industry Growth – Microsoft (NASDAQ:MSFT)

    September 26, 2023

    Ideal World TV Channel Makes a Grand Return with an Unbeatable Selection of Lifestyle Products

    September 26, 2023

    Mount Sinai Announces New System Chief of Genomic Medicine

    September 26, 2023

    Nat-Gas Prices Decline Due to Warm U.S. Autumn Temperatures

    September 26, 2023

    Brent Crude – Oil Pares Gains in Risk-Averse Trade

    September 26, 2023

    Upwing Energy to Exhibit at SPE Gulf Coast Section Electric Submersible Pumps Symposium, Display Subsurface Compressor System™

    September 26, 2023

    Crude Prices Rise Due to Expectations of Limited Global Oil Supplies

    September 26, 2023

    Aeroflow Healthcare Celebrates Success with Ohio’s Inclusion of Diaper Tax Exemption in HB 33

    September 26, 2023

    Stocks Plunge as Confidence in the U.S. Economic Outlook Declines

    September 26, 2023

    17 Greenberg Traurig Attorneys Named 2023 LMG Life Sciences Guide ‘Life Science Stars’

    September 26, 2023

    Costco (NASDAQ:COST) Exceeds Q4 Expectations

    September 26, 2023

    When will the stock-market pain end? Here are 3 clues investors should watch for.

    September 26, 2023

    Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

    September 26, 2023

    What’s In Store For CarMax In Q2 – Analyst Sees Easing Growth Comparisons, Cost Controls & More – CarMax (NYSE:KMX)

    September 26, 2023

    Oppenheimer Maintains U.S. Bancorp. (USB) Outperform Recommendation

    September 26, 2023
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report
Get Access
Virtus Junxit EquitiesVirtus Junxit Equities
Home»Press Releases»Joel Seth Aronson, RPh, Featured in Marquis Who’s Who Millennium Magazine
Press Releases

Joel Seth Aronson, RPh, Featured in Marquis Who’s Who Millennium Magazine

James TaylorBy James TaylorSeptember 15, 2023Updated:September 15, 2023No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email




  • Slider Image

NATICK, MA, September 15, 2023 /24-7PressRelease/ — Joel Seth Aronson, RPh, retired clinical pharmacy specialist from the Veteran Affairs Medical Center, has been selected for a cover feature in the Thirteenth Edition of Marquis Millennium Magazine. Released triannually, Millennium Magazine features the narrative biographies of the world’s most esteemed and accomplished professionals. The publication is available exclusively to Marquis listees, and inclusion is by invitation only.

Discovering his passion for chemistry early in his life, Joel Seth Aronson pursued a career in the pharmaceutical industry by working at an Eckerd Drugs warehouse in Florida one summer. He earned a Bachelor of Science in pharmacy from the College of Pharmacy at the University of Louisiana at Monroe in 1972. He obtained his license as a pharmacist in Louisiana in 1973 and completed a pharmacy internship at Steven’s Pharmacy in Boston. From 1973 to 1974, he worked at Brookline Pharmacy as a pharmacy graduate intern. Afterward, Mr. Aronson reciprocated his pharmacy license to Massachusetts in 1974 and passed the Florida Pharmacy Board examination in 1975.

To read more about Mr. Aronson in Millennium Magazine, please visit the Thirteenth Edition online:
https://marquismillennium.com/13th_Ed/joel-aronson
https://marquismillennium.com/13th_Ed/joel-aronson/260

About Marquis Who’s Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America®, Marquis Who’s Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion, and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who’s Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians, and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who’s Who® website at www.marquiswhoswho.com.

# # #


PRESS RELEASE
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleWhat’s Happening with AMD Stock on Friday?
Next Article What’s Happening with Canopy Growth Stock Today?
James Taylor
  • Website
  • X (Twitter)

A writer and finance enthusiast who loves diving into the exciting world of stocks, commodities, forex, and crypto. I'm all about making the financial markets less intimidating and more accessible, so I write engaging content that simplifies complex concepts and shares practical investment strategies. Whether you're a seasoned investor or just getting started, I've got your back! But hey, life isn't all about work, right? On weekends, you'll find me hanging out and having a blast with my awesome friends and family. We love bonding over shared interests, trying out new adventures, and simply enjoying each other's company. Striking that balance between work and play is super important to me, because what's the point of success if you can't share it with the people you love? So, if you're up for some financial market insights and a good dose of weekend fun, stick around! Together, we'll navigate the money world and make the most of our time off. Let's learn, grow, and create memories along the way!

Related Posts

Ripcord Joins AWS ISV Accelerate Program

September 26, 2023By James Taylor0

Craig DuKate Celebrated for Dedication to the Construction Industry

September 26, 2023By James Taylor0

Lawrence David Goldstein has been Inducted into the Prestigious Marquis Who’s Who Biographical Registry

September 26, 2023By James Taylor0

Leave A Reply Cancel Reply

Our Picks
Technology

American Society for Clinical Pathology Awarded $631,983 Grant from the CDC to Strengthen the Laboratory Workforce

By James TaylorSeptember 26, 2023
Financial Services

Aeroflow Healthcare Celebrates Success with Ohio’s Inclusion of Diaper Tax Exemption in HB 33

By James TaylorSeptember 26, 2023
Technology

OpenAI Discusses Share Sale: Potential $90B Valuation Signals AI Industry Growth – Microsoft (NASDAQ:MSFT)

By James TaylorSeptember 26, 2023
Financial Services

Stocks Plunge as Confidence in the U.S. Economic Outlook Declines

By James TaylorSeptember 26, 2023
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Trending

Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

By James TaylorSeptember 26, 2023

Cantor Fitzgerald has maintained its coverage of Soleno Therapeutics (NASDAQ: SLNO) with an Overweight recommendation, according to Fintel. Analysts forecast a 183.97% upside for Soleno Therapeutics, with an average one-year price target of 12.58. The price targets range from a low of 8.08 to a high of $19.95. This represents…

What’s In Store For CarMax In Q2 – Analyst Sees Easing Growth Comparisons, Cost Controls & More – CarMax (NYSE:KMX)

September 26, 2023

Oppenheimer Maintains U.S. Bancorp. (USB) Outperform Recommendation

September 26, 2023

If You Invested $2,000 in PubMatic in 2020, This Is How Much You Would Have Today

September 26, 2023
FEATURED INSIGHTS​
Top Stories

When will the stock-market pain end? Here are 3 clues investors should watch for.

By James TaylorSeptember 26, 2023
Trending

Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

By James TaylorSeptember 26, 2023
Trading Insights

What’s In Store For CarMax In Q2 – Analyst Sees Easing Growth Comparisons, Cost Controls & More – CarMax (NYSE:KMX)

By James TaylorSeptember 26, 2023

Subscribe to stay informed!

Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

Telegram RSS
  • Home
  • Privacy Policy
  • Disclaimer
  • Virtus Report
  • Get Access
  • About Us
© 2023 Virtus Junxit LLC

Type above and press Enter to search. Press Esc to cancel.